Trials / Completed
CompletedNCT01097681
A Study to Assess the Pharmacokinetics, Pharmacodynamics of ASP1941 in Diabetes Mellitus Patients With Renal Impairment
An Open-Label Study to Assess the Effect of Different Grades of Renal Impairment in Japanese Patients With Type 2 Diabetes Mellitus on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP1941 Relative to Type 2 Diabetes Mellitus Patients With Normal Renal Function
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to compare the pharmacokinetics of ASP1941 in type 2 diabetes mellitus patients with normal renal function and those with mild or moderate renal impairment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP1941 | oral |
Timeline
- Start date
- 2010-02-16
- Primary completion
- 2010-06-18
- Completion
- 2010-06-18
- First posted
- 2010-04-02
- Last updated
- 2024-11-12
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01097681. Inclusion in this directory is not an endorsement.